Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes.
Di Leone A, Terribile D, Magno S, Sanchez AM, Scardina L, Mason EJ, D'Archi S, Maggiore C, Rossi C, Di Micco A, Carnevale S, Paris I, Marazzi F, Masiello V, Orlandi A, Palazzo A, Fabi A, Masetti R, Franceschini G. Di Leone A, et al. Among authors: palazzo a. J Pers Med. 2021 Apr 21;11(5):324. doi: 10.3390/jpm11050324. J Pers Med. 2021. PMID: 33919061 Free PMC article. Review.
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors.
Garufi G, Palazzo A, Paris I, Orlandi A, Cassano A, Tortora G, Scambia G, Bria E, Carbognin L. Garufi G, et al. Among authors: palazzo a. Expert Opin Pharmacother. 2020 Apr;21(6):687-699. doi: 10.1080/14656566.2020.1724957. Epub 2020 Feb 13. Expert Opin Pharmacother. 2020. PMID: 32052646 Review.
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series.
Orlandi A, Iattoni E, Pizzuti L, Fabbri A, Botticelli A, Di Dio C, Palazzo A, Garufi G, Indellicati G, Alesini D, Carbognin L, Paris I, Vaccaro A, Moscetti L, Fabi A, Magri V, Naso G, Cassano A, Vici P, Giannarelli D, Franceschini G, Marchetti P, Bria E, Tortora G. Orlandi A, et al. Among authors: palazzo a. J Pers Med. 2020 Dec 18;10(4):291. doi: 10.3390/jpm10040291. J Pers Med. 2020. PMID: 33353132 Free PMC article.
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis.
Orlandi A, Pontolillo L, Mele C, Pasqualoni M, Pannunzio S, Cannizzaro MC, Cutigni C, Palazzo A, Garufi G, Vellone M, Ardito F, Franceschini G, Sanchez AM, Cassano A, Giuliante F, Bria E, Tortora G. Orlandi A, et al. Among authors: palazzo a. J Pers Med. 2021 Mar 8;11(3):187. doi: 10.3390/jpm11030187. J Pers Med. 2021. PMID: 33800160 Free PMC article.
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis.
Orlandi A, D'Archi S, Garufi G, Franco A, Carnassale B, Palazzo A, Bria E, Sanchez M, DI Leone A, Terribile D, Fabi A, Tortora G, Masetti R, Franceschini G. Orlandi A, et al. Among authors: palazzo a. Minerva Surg. 2021 Dec;76(6):506-511. doi: 10.23736/S2724-5691.21.09007-9. Epub 2021 Aug 2. Minerva Surg. 2021. PMID: 34338469
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.
Duranti S, Fabi A, Filetti M, Falcone R, Lombardi P, Daniele G, Franceschini G, Carbognin L, Palazzo A, Garganese G, Paris I, Scambia G, Pietragalla A. Duranti S, et al. Among authors: palazzo a. Cancers (Basel). 2021 Oct 16;13(20):5198. doi: 10.3390/cancers13205198. Cancers (Basel). 2021. PMID: 34680350 Free PMC article. Review.
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience.
Di Leone A, Franco A, Terribile DA, Magno S, Fabi A, Sanchez AM, D'Archi S, Scardina L, Natale M, Mason EJ, Murando F, Marazzi F, Orlandi A, Paris I, Visconti G, Palazzo A, Masiello V, Barone Adesi L, Salgarello M, Masetti R, Franceschini G. Di Leone A, et al. Among authors: palazzo a. Cancers (Basel). 2022 Mar 1;14(5):1275. doi: 10.3390/cancers14051275. Cancers (Basel). 2022. PMID: 35267583 Free PMC article.
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Garufi G, Carbognin L, Arcanà C, Parola S, Ventriglia A, Doronzo A, Garutti M, Orlandi A, Palazzo A, Fabi A, Bria E, Tortora G, Arpino G, Giuliano M, Del Mastro L, De Laurentiis M, Puglisi F. Garufi G, et al. Among authors: palazzo a. Cancer Treat Rev. 2022 Nov;110:102454. doi: 10.1016/j.ctrv.2022.102454. Epub 2022 Aug 11. Cancer Treat Rev. 2022. PMID: 35987149 Review.
280 results